Company intelligence / Profile preview

Market News First

Dallas, Texas, United States

Ownership: Private
Development stage: Other

Overview

Market News First (MN1) is a multi-media news organization that provides digital broadcasting and reporting services focused on the financial markets, with a specialized niche in the biotechnology and life sciences sectors. The company produces video interviews, press release distributions, and news articles designed to increase the visibility of small-cap and mid-cap public companies. While it provides extensive coverage of clinical trials and healthcare innovations, MN1 operates strictly as a media and investor relations platform and does not develop its own therapeutic products. The platform was particularly active in the mid-2000s and 2010s as a source for micro-cap biotech news.

Industry: Consulting

Beyond the preview

Go deeper on Market News First.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Market News First.

Explore the full profile